tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PRME Stock Latest News

Prime Medicine price target raised to $16 from $15 at Chardan
The FlyPrime Medicine price target raised to $16 from $15 at Chardan
8d ago
PRME
Prime Medicine, Inc.: Promising Future in Gene Editing with Innovative AATD Program and Strategic Growth Potential
PremiumRatings
Prime Medicine, Inc.: Promising Future in Gene Editing with Innovative AATD Program and Strategic Growth Potential
9d ago
PRME
Prime Medicine, Inc.: Innovative Prime Editing Platform Targets Unmet Medical Needs with Promising Preclinical Results
PremiumRatings
Prime Medicine, Inc.: Innovative Prime Editing Platform Targets Unmet Medical Needs with Promising Preclinical Results
9d ago
PRME
Prime Medicine’s Promising Advancements in Liver-Targeting AATD Program with Prime Editing Technology
PremiumRatings
Prime Medicine’s Promising Advancements in Liver-Targeting AATD Program with Prime Editing Technology
9d ago
PRME
Prime Medicine, Inc.: Innovative Prime Editing Technology and Promising Preclinical Results Drive Buy Rating
PremiumRatings
Prime Medicine, Inc.: Innovative Prime Editing Technology and Promising Preclinical Results Drive Buy Rating
9d ago
PRME
Prime Medicine Advances AATD Program with Promising Preclinical Results
PremiumCompany AnnouncementsPrime Medicine Advances AATD Program with Promising Preclinical Results
10d ago
8K
PRME
Prime Medicine unveils program for treatment of AATD
Premium
The Fly
Prime Medicine unveils program for treatment of AATD
10d ago
PRME
Prime Medicine, Inc.: Strategic Advancements and Promising Financial Outlook Drive Buy Rating
Premium
Ratings
Prime Medicine, Inc.: Strategic Advancements and Promising Financial Outlook Drive Buy Rating
10d ago
PRME
Prime Medicine’s Advancements and Financial Strength Support Buy Rating Amid Promising Developments in Gene Editing and Rare Diseases
PremiumRatings
Prime Medicine’s Advancements and Financial Strength Support Buy Rating Amid Promising Developments in Gene Editing and Rare Diseases
24d ago
PRME
Prime Medicine, Inc.: Promising Gene Editing Developments and Strong Financial Position Justify Buy Rating
PremiumRatings
Prime Medicine, Inc.: Promising Gene Editing Developments and Strong Financial Position Justify Buy Rating
25d ago
PRME
Prime Medicine Reports 2024 Financial Results and Progress
PremiumCompany Announcements
Prime Medicine Reports 2024 Financial Results and Progress
27d ago
PRME
Prime Medicine reports FY24 EPS ($1.65) vs ($2.18) last year
PremiumThe Fly
Prime Medicine reports FY24 EPS ($1.65) vs ($2.18) last year
28d ago
PRME
Chardan unveils four top biotech picks for 2025
PremiumThe FlyChardan unveils four top biotech picks for 2025
2M ago
RNA
MGTX
Prime Medicine Advances Gene Editing and Trials
Premium
Company Announcements
Prime Medicine Advances Gene Editing and Trials
2M ago
8K
PRME
Prime Medicine files to sell 11.01M shares of common stock for holders
Premium
The Fly
Prime Medicine files to sell 11.01M shares of common stock for holders
3M ago
PRME
Prime Medicine initiated with an Outperform at JMP Securities
PremiumThe Fly
Prime Medicine initiated with an Outperform at JMP Securities
4M ago
PRME
Prime Medicine Reports Q3 2024 Financial Progress
PremiumCompany Announcements
Prime Medicine Reports Q3 2024 Financial Progress
4M ago
PRME
Prime Medicine reports Q3 EPS (44c), consensus (44c)
PremiumThe Fly
Prime Medicine reports Q3 EPS (44c), consensus (44c)
5M ago
PRME
Is PRME a Buy, Before Earnings?
PremiumPre-Earnings
Is PRME a Buy, Before Earnings?
5M ago
PRME
Prime Medicine treatment of retinal dystrophy granted orphan designation
PremiumThe FlyPrime Medicine treatment of retinal dystrophy granted orphan designation
5M ago
PRME
Prime Medicine Advances Gene Editing for Liver Diseases
Premium
Company Announcements
Prime Medicine Advances Gene Editing for Liver Diseases
5M ago
8K
PRME
Prime Medicine presents data from multiple studies showcasing LNP platform
Premium
The Fly
Prime Medicine presents data from multiple studies showcasing LNP platform
5M ago
PRME

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >